Literature DB >> 1676820

Polypharmacy in fatal clozapine-associated agranulocytosis.

S L Gerson, J A Lieberman, W R Friedenberg, D Lee, J J Marx, H Meltzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1676820     DOI： 10.1016/0140-6736(91)90410-q

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

Review 2.  Mechanisms of clozapine-induced agranulocytosis.

Authors:  S L Gerson; H Meltzer
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

Review 3.  Continuing clozapine treatment despite neutropenia.

Authors:  David Esposito; Frédéric Rouillon; Frédéric Limosin
Journal:  Eur J Clin Pharmacol       Date:  2004-11-30       Impact factor: 2.953

Review 4.  Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Authors:  Eromona Whiskey; David Taylor
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 5.  Anticonvulsant drugs and hematological disease.

Authors:  A Verrotti; A Scaparrotta; S Grosso; F Chiarelli; G Coppola
Journal:  Neurol Sci       Date:  2014-03-12       Impact factor: 3.307

6.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

7.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 8.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

9.  Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia.

Authors:  Al Aditya Khan; Jake Harvey; Samrat Sengupta
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

10.  Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.

Authors:  Kristin N Maher; Marcus Tan; Julia W Tossell; Brian Weisinger; Peter Gochman; Rachel Miller; Deanna Greenstein; Gerald P Overman; Judith L Rapoport; Nitin Gogtay
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.